Arbutus Biopharma
ABUS
#6189
Rank
โ‚ฌ0.75 B
Marketcap
3,92ย โ‚ฌ
Share price
2.91%
Change (1 day)
9.78%
Change (1 year)

Revenue for Arbutus Biopharma (ABUS)

Revenue in 2025 (TTM): โ‚ฌ13.45 Million

According to Arbutus Biopharma 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ13.16 Million. In 2024 the company made a revenue of โ‚ฌ5.93 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ16.41 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arbutus Biopharma from 2008 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ13.45 M126.91%
2024 โ‚ฌ5.93 M-63.86%
2023 โ‚ฌ16.41 M-54.89%
2022 โ‚ฌ36.37 M274.91%
2021 โ‚ฌ9.7 M72.6%
2020 โ‚ฌ5.62 M4.76%
2019 โ‚ฌ5.36 M3.26%
2018 โ‚ฌ5.19 M-41.73%
2017 โ‚ฌ8.91 M529.12%
2016 โ‚ฌ1.41 M-93.77%
2015 โ‚ฌ22.74 M85.02%
2014 โ‚ฌ12.29 M9.7%
2013 โ‚ฌ11.2 M5.79%
2012 โ‚ฌ10.59 M-18.55%
2011 โ‚ฌ13 M-18.9%
2010 โ‚ฌ16.03 M75.6%
2009 โ‚ฌ9.13 M30.47%
2008 โ‚ฌ7 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚ฌ0.11 B 802.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas